购物车
  • TargetMol
    您的购物车当前为空

Tamsulosin

一键复制产品信息
Rating icon 很棒

纯度: 99.93%

货号 T0210LCas号 106133-20-4

别名 坦索罗辛, LY253351 free base, HSDB-7744, HSDB7744, HSDB 7744, Harnal-D, Flowmax, (R)-(-)-YM12617 free base

Tamsulosin ((R)-(-)-YM12617 free base) 是一种肾上腺素能受体α 1A 拮抗剂,用于良性前列腺增生(BPH)的治疗。Tansulosin 用于治疗排尿困难,这是前列腺肥大的一种常见症状。Tansulosin 和其他被称为α受体阻滞剂的药物通过放松膀胱颈部肌肉和前列腺本身的肌肉纤维来发挥作用,使其更容易排尿。

Tamsulosin
其他形式的 “Tamsulosin”:

Tamsulosin

一键复制产品信息
Rating icon 很棒

纯度: 99.93%

货号 T0210L 别名 坦索罗辛, LY253351 free base, HSDB-7744, HSDB7744, HSDB 7744, Harnal-D, Flowmax, (R)-(-)-YM12617 free baseCas号 106133-20-4

Tamsulosin ((R)-(-)-YM12617 free base) 是一种肾上腺素能受体α 1A 拮抗剂,用于良性前列腺增生(BPH)的治疗。Tansulosin 用于治疗排尿困难,这是前列腺肥大的一种常见症状。Tansulosin 和其他被称为α受体阻滞剂的药物通过放松膀胱颈部肌肉和前列腺本身的肌肉纤维来发挥作用,使其更容易排尿。

规格价格库存数量
5 mg
¥ 139
现货
10 mg
¥ 189
现货
25 mg
¥ 313
现货
50 mg
¥ 446
现货
1 mL x 10 mM (in DMSO)
¥ 153
现货
库存状态实时更新,以官网显示为准,现货产品可直接加购物车下单
大包装 & 定制
加入购物车
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
实验操作小课堂
常见问题解答
查看更多
选择批次:
纯度: 99.93%
联系我们 获取更多批次信息

产品介绍


Tamsulosin AI Summary
Tamsulosin is a highly potent compound with significant binding affinity across multiple adrenergic receptor subtypes. It displays exceptionally low Ki values for human Alpha-1A (0.029 nM), Alpha-1B (0.61 nM), and Alpha-1D (0.058 nM) receptors, suggesting high potency. It also shows noteworthy affinities for Alpha-2A (13.4 nM) and Alpha-2C (7.9 nM) receptors, along with rat Alpha-2B adrenergic receptor (6.8 nM). In various assays, Tamsulosin demonstrated powerful in vitro antagonism, particularly against human Alpha-1A, Alpha-1B, and Alpha-1D adrenergic receptors with further confirmation of its in vivo efficacy in an intraurethral pressure model in aged anesthetized dogs (Kd = 1.349 nM) and a spontaneously hypertensive rat model (pED50 = 7.33). The compound also exhibited inhibition of A61603-induced contraction in rats with an AD50 of 3.0 µg/kg, maintaining efficacy over 3.5 hours. Furthermore, Tamsulosin showed high affinity for human cloned Alpha-1A, Alpha-1B, and Alpha-1D receptors, with Ki values of 0.19 nM, 2.0 nM, and 0.2 nM, respectively. In pharmacokinetic evaluations, Tamsulosin displayed high oral bioavailability (Fa = 1.0), efficient evasion of hepatic elimination (Fh = 0.98), and moderate clearance rates (CL = 0.62 mL/min/kg). It exhibited a half-life of 6.8 hours in humans post-intravenous administration and a low fraction unbound (Fu = 0.01), with a steady-state volume of distribution (Vdss) of 0.21 L/kg, indicating extensive distribution across body tissues. Notably, there was no evidence of liver toxicity (DILI severity class of 0.0). Moreover, Tamsulosin possesses antagonistic activity on Alpha-1A, Alpha-1B, and Alpha-1D adrenoceptors, which is demonstrated through various IC50 values, supporting its potential in modulating adrenergic signaling pathways. In antiviral assessments, although weak against SARS-CoV-2 (hit score 0.1193), it showed 22.04% inhibition of the SARS-CoV-2 3CL-Pro protease at 20 µM concentration. The compound also illustrated a degree of enzymatic inhibition, targeting human HDAC6 and MAOA, among other enzymes. These collective pharmacological characteristics suggest Tamsulosin as a promising candidate for therapeutic applications involving adrenergic receptor modulation, with a broad spectrum of potential bioactivities..
Note: Summary generated by AI. Data source: ChEMBL
生物活性
产品描述
Tamsulosin ((R)-(-)-YM12617 free base) is an alpha1A adrenergic receptor antagonist for the symptomatic treatment of benign prostatic hyperplasia (BPH). Tamsulosin is used to treat difficulty urinating, a common symptom of an enlarged prostate. Tansulosin and other drugs called alpha blockers work by relaxing the neck muscles of the bladder and muscle fibers in the prostate itself, making it easier to urinate.
别名坦索罗辛, LY253351 free base, HSDB-7744, HSDB7744, HSDB 7744, Harnal-D, Flowmax, (R)-(-)-YM12617 free base
化学信息
分子量408.51
分子式C20H28N2O5S
CAS No.106133-20-4
SmilesCCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(c1)S(N)(=O)=O
密度1.191 g/cm3
储存&溶解度
存储Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
溶解度信息
DMSO: 90 mg/mL (220.31 mM), Sonication is recommended.
体内实验配方
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (8.08 mM), Sonication is recommended.
请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。
溶液配制表
DMSO
1mg5mg10mg50mg
1 mM2.4479 mL12.2396 mL24.4792 mL122.3960 mL
5 mM0.4896 mL2.4479 mL4.8958 mL24.4792 mL
10 mM0.2448 mL1.2240 mL2.4479 mL12.2396 mL
20 mM0.1224 mL0.6120 mL1.2240 mL6.1198 mL
50 mM0.0490 mL0.2448 mL0.4896 mL2.4479 mL
100 mM0.0245 mL0.1224 mL0.2448 mL1.2240 mL

计算器

  • 摩尔浓度 计算器
  • 稀释 计算器
  • 配液 计算器
  • 分子量 计算器

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
TargetMol | Animal experiments 比如您的给药剂量是10 mg/kg,每只动物体重20g,给药体积100 μLTargetMol | Animal experiments 一共给药动物10只,您使用的配方为5%TargetMol | reagent DMSO + 30%PEG300 + 5%Tween 80 + 60%Saline/PBS/ddH2O, 那么您的工作液浓度为2mg/mL
母液配置方法: 2 mg 药物溶于 50 μLDMSOTargetMol | reagent ( 母液浓度为 40 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:50μLDMSOTargetMol | reagent 母液,添加 300 μLPEG300TargetMol | reagent 混匀澄清,再加 50μLTween80, 混匀澄清,再加 600μLSaline/PBS/ddH2OTargetMol | reagent 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSOPEG300 / PEG400Tween 80SBE-β-CD玉米油 等, 均可在TargetMol网站点击购买。
1 请输入动物实验的基本信息
mg/kg
g
μL
2 请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

剂量转换

对于不同动物的给药剂量换算,您也可以参考 更多

Related Tags: buy Tamsulosin | purchase Tamsulosin | Tamsulosin cost | order Tamsulosin | Tamsulosin chemical structure | Tamsulosin formula | Tamsulosin molecular weight